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AdhesionA series of drug-in-adhesive transdermal drug delivery systems (patch) with different chemical
penetration enhancers were designed to deliver drug through the skin as a site of application.
The objective of our effort was to study the inﬂuence of various chemical penetration enhancers
on skin permeation rate and adhesion properties of a transdermal drug delivery system using
Box–Behnken experimental design. The response surface methodology based on a three-level,
three-variable Box–Behnken design was used to evaluate the interactive effects on dependent
variables including, the rate of skin permeation and adhesion properties, namely peel strength
and tack value. Levulinic acid, lauryl alcohol, and Tween 80 were used as penetration enhancers
(patch formulations, containing 0–8% of each chemical penetration enhancer). Buprenorphine
was used as a model penetrant drug. The results showed that incorporation of 20% chemical
penetration enhancer into the mixture led to maximum skin permeation ﬂux of buprenorphine
from abdominal rat skin while the adhesion properties decreased. Also that skin ﬂux in presence
of levulinic acid (1.594 lg/cm2 h) was higher than Tween 80 (1.473 lg/cm2 h) and lauryl alcohol
(0.843 lg/cm2 h), and in mixing these enhancers together, an additional effect was observed.
Moreover, it was found that each enhancer increased the tack value, while levulinic acid and
lauryl alcohol improved the peel strength but Tween 80 reduced it. These ﬁndings indicated that
the best chemical skin penetration enhancer for buprenorphine patch was levulinic acid. Among
the designed formulations, the one which contained 12% (wt/wt) enhancers exhibited the high-
est efﬁciency.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Cairo University.Introduction
A recent approach in drug delivery system is administering
drugs with speciﬁc rates through skin as the site of application.
In the past decade, much attention has been paid to a speciﬁc
transdermal drug delivery system (TDD), also known as
‘‘patch’’ system [1]. This system has many advantages such
as the elimination of the ﬁrst pass effect and its side effects with
156 S.M. Taghizadeh et al.steady delivery of medicine over long period of time [2]. Nev-
ertheless, this system has some limitations. It is known that
some agents such as penetration enhancers and pressure sensi-
tive adhesives can have inﬂuence on skin permeation ﬂux and
adhesive properties of TDDs [3–5]. Buprenorphine is a par-
tially opiate drug with an analgesic potency of about 25–50
times higher than an equivalent dose of morphine. This drug
has sufﬁciently low molecular weight with lipophilic properties
so it can be a suitable candidate to be administered by TDDs.
This drug has been used to relieve chronic and cancer pain via
several routes such as sublingual and transdermal [6,7]. Trans-
tec is a transdermal formulation of buprenorphine which has
become available in three dosage levels [8]. Although transder-
mal drug delivery has many advantages in relation to inherent
barrier properties of the skin, but as yet it is not widely
used. Many different approaches have been adopted to
overcome the barrier properties of skin, such as mechanical
and chemical penetration enhancers. Therefore, chemical
penetration enhancers are used in TDDs to increase the diffu-
sion rates of drugs to overcome the resistance of stratum
corneum [9].
Although there are some literature sources that have
evaluated the effects of chemical penetration enhancers on skin
permeation ﬂux and mode of behavior of different hydrophilic
and hydrophobic drugs, but no report has been published yet
on the role of buprenorphine with respect to skin permeation
ﬂux and adhesion properties of the ﬁnal patches using an
adhesive with carboxylic functionality incorporated with lauric
alcohol, leuvinic acid, and a surfactant such as Tween 80, as
skin penetration enhancers into the formulations. In the pres-
ent work, the optimization of the ﬁnal desirable formulations
for skin permeation ﬂux and adhesion properties was also
accomplished by Box–Behnken method as a statistical tool
and that such combination has not been tried before by other
researchers.
The objective of the present work was to design new TDDs
with an acrylic adhesive and different types and concentrations
of chemical penetration enhancers (CPE) and to study their
skin permeation ﬂux and adhesion properties. For this purpose
the best formulation was selected by employing response
surface experimental design method. Therefore, levulinic acid,
lauryl alcohol, and Tween 80 were used as penetration
enhancers as variable parameters in order to evaluate their
effects on skin permeation ﬂux and adhesion properties of
their corresponding systems.Material and methods
Materials
Acrylic adhesive Duro-Tak 87-2196 was purchased from
National Starch and Chemical Company, USA. Tween 80
and levulinic acid (LEA) were obtained from Merck,
Germany. Lauryl alcohol (LA) was supplied by Fluka, USA.
Buprenorphine, as an active ingredient, was obtained from
Behansar Pharmaceutical Company, Iran. The backing layer
with thickness of 85 lm and Scotchpak1022 as a release liner
was provided from 3 M Company, USA. All solvents of
high-performance liquid chromatography (HPLC) grades were
purchased from Merck, Germany.Determination of buprenorphine
The standard and real samples of buprenorphine were analyzed
by HPLC (Younglin, SDV30) with UV detector at 285 nm. The
HPLC separation system consisted of a PerfectSil Target C18
column (150 · 4.6 mm, 5 lm) equipped with a guard column
(10 · 4.0 mm, 5 lm); the temperature of HPLC column was
maintained at 40 C. The mobile phase consisted of acetoni-
trile/KH2PO4 10 mM (45:55) with pH 3.0 ± 0.1 (adjusted by
phosphoric acid) at 1 ml/min ﬂow rate, and the volume of injec-
tion was set at 20 ll. A standard stock solution of buprenor-
phine (1000 lg mL1) was prepared in methanol. Calibration
standard solutions of 0.5, 1, 5, 10, 15, 20, 30 lg/ml of buprenor-
phine were prepared by further dilution of a stock standard
solution in phosphate buffer (pH 6). All of these solutions were
stored in a refrigerator (4 C) and brought to ambient temper-
ature just prior to use. Each peak area was plotted against its
corresponding concentration to obtain the calibration graph.
The data of peak area versus concentration were treated by lin-
ear least square regression analysis. The method was validated
according to the ICH guidelines [10]. The validation character-
istics included accuracy, precision, linearity range, selectivity,
limit of detection (LOD), and limit of quantitation (LOQ).
The results showed a good correlation between analyte peak
area and concentration with (r2 = 0.9990). The limit of detec-
tion (LOD) and limit of quantitation (LOQ) in the release med-
ia were 0.15 and 0.5 lg mL1, respectively. Also, to evaluate
the performance of the proposed method, it was used in the
analysis of buprenorphine level in real samples.
Sample preparation
The preparation of buprenorphine patches was performed in
two stages. At ﬁrst, the pressure sensitive adhesive (Duro-
Tak 87-2196) was thoroughly mixed with each chemical pene-
tration enhancer and buprenorphine in a rotary mixer at room
temperature to prepare formulations as given in Table 1. In the
next step, the mixed solutions (total weight of each solution:
2 g) were coated on the 5 \ 5 cm2 backing layer (outermost
layer) of the patch by an Elcometer ﬁlm applicator (3580
SPRL 75 mm) to obtain a layer with uniform thickness
(80 lm). Next, the prepared ﬁlm was kept at ambient temper-
ature for 20 min and then placed in an oven of 50 C for
40 min to remove the remaining solvent completely [11].
Skin preparation for permeation study
Male Sprague–Dawley rats, each weighing 250 ± 25 g, supplied
byRazi Vaccine and SerumResearch Institutewere anesthetized
with ether. The abdominal hair of each rat was shaved by hand
razors, and a 5 · 5 cm2 area of a full thickness abdominal skin
was surgically removed. For removal of the residual fat, the der-
mis section of the skin was soaked in isopropyl alcohol. The skin
was brought into contact with normal saline 1h before sampling
from the diffusion cell [12–14]. All Institutional and National
Guidelines for the care and use of animals were followed.
Permeation study
Permeation studies of buprenorphine from a drug-in-adhesive
patch were performed in a well-characterized Chien diffusion
Table 1 Formulation components as independent variables (wt/wt%).
Run
(randomly)
Run
(formulation number)
Lauryl alcohol
(wt/wt%)
Tween 80
(wt/wt%)
Levulinic acid
(wt/wt%)
Adhesive
(wt/wt%)
Buprenorphine
content (wt/wt%)
4 1 0 4 8 80 8
13 2 8 8 4 72 8
1 3 4 0 8 80 8
2 4 0 0 4 88 8
10 5 0 8 4 80 8
3 6 8 0 4 80 8
15 7 4 8 8 72 8
7 8 4 4 4 80 8
5 9 4 0 0 88 8
6 10 0 4 0 88 8
8 11 4 8 0 80 8
11 12 4 4 4 80 8
12 13 4 4 4 80 8
9 14 8 4 0 80 8
14 15 8 4 8 72 8
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of 37 C. The receptor compartment was ﬁlled with 3 ml phos-
phate buffer solution of pH 6 as a receptor medium. The pre-
pared skin was cut by about 1.5 · 1.5 cm2 dimension and put
on the receptor cell, and the transdermal patch was applied
onto the stratum corneum (SC) of the skin. At each predeter-
mined time interval (1, 2, 4, 8, 12, 24, 36, 48, 56, 72 and
96 h), a deﬁnite volume (3 ml) of solution was withdrawn from
the receptor compartment which was immediately compen-
sated by an equal volume of fresh phosphate buffer. Finally,
the drug concentration of each sample was determined by a
Younglin HPLC analyzer (SDV30) [13,15].
Data analysis
The skin ﬂux of buprenorphine through the abdominal skin
was calculated by plotting the cumulative amount of bupr-
enorphine permeated through skin versus time. The steady
state ﬂux and lag time were estimated from the slope of the lin-
ear region of the obtained graph and its intercept on the X-
axis, respectively [16].
Scanning electron microscopy (SEM)
Scanning electron microscopy (SEM) was performed on
VEGA/TESCAN model operating at an accelerating voltage
of 20 kV and magniﬁcation of 10,000·. The specimens were
cryogenically fractured in liquid nitrogen and coated by a thin
layer of gold to improve resolution.
Probe tack test
Tack tests were performed on all samples, each with 80 lm
thickness, according to (ASTM D-2979), by using a Chemie
Instrument Probe Tack-500 (Fair Field, Ohio, USA) for at
least ﬁve samples [13].
Peel strength measurement at 180
Peel tests on adhesive-coated tapes were carried out according
to ASTM D-3330 [13]. The samples, each 2.5 · 2.5 cm2, wereadhered to a stainless steel as a test panel and then rolled twice
with a 4.5 kg roller to bond it to the test panel ﬁrmly. The tests
were measured at a peel rate of 300 mm/min by using a Chemie
Instrument adhesive/release tester AR-1000 (Fair Field, Ohio,
USA). The test was repeated at least ﬁve times on 5 identical
samples.
Thermal analysis
The glass transition temperature (Tg) of various formulations
was measured by differential scanning calorimeter (DSC) on
a PL-1500 with heating rate of 10 C/min under N2 atmo-
sphere. It should be noted that exactly the same sample prep-
aration steps, given in sample preparation method, were
adopted for all samples except with different coating. Each test
sample was coated on the release liner while the main sample
was coated on the backing layer. The reason of such action
was that at the time of testing, the coated layer needed to be
separated from release liner for conducting such test.
Experimental design
The Design-Expert 6.0.0 software of response surface method
was used to estimate the coefﬁcient of model for statistical de-
sign of the experiments [17]. A response surface methodology
(RSM) using Box–Behnken design, with three factors and
three levels, was performed to investigate the effect of variable
factors on system’s response. Some factors in the analysis of
variance table such as prediction of multiple correlation coef-
ﬁcients (prediction R2), adjusted R2, lack of ﬁt, and P-value
were important for selection of adequate models [18,19]. The
modiﬁed quadratic was selected as a good ﬁt for model. The
concentration effects of levulinic acid (LEV), lauryl alcohol
(LA), and Tween 80 (T), as independent variables, on skin per-
meation, tack value, and peel strength were investigated. In
Box–Behnken design, the experimental points were placed on
a hypersphere with some characteristics as follows:
 Number of experiments obtained from N= 2 k (k  1) +
Cp where k would be the number of factors and Cp the
number of central points.
 All factor levels adopted at three levels.
Fig. 1 Response surface for skin permeation ﬂux versus (A) for
LA and LEV at T = 4% and (B) for LA and T at LEV = 4%.
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tors and three levels, and they were augmented with three rep-
lications at the central point to estimate ‘‘pure error.’’ A
polynomial model, to include interactions and quadratic
terms, was adopted as follows:
Y ¼ b0 þ
Xk
i¼1
bixi þ
Xk
i¼1
biix
2
ii þ
Xk
i¼1
Xk
i6jj
bijxixj þ e ð1Þ
where Y denoting the response; k as the number of variables; xi
symbolizing the independent variables; e the residual associ-
ated to the experiments; b0 the constant of coefﬁcient; and
bi, bii, and bij representing the coefﬁcients of the linear, qua-
dratic, and interaction parameters, in the order given.
For Box–Behnken model, with three variable factors and
three levels (k= 3), the Eq. (1) was expanded as follows
[17,19,20]
Y ¼ b0 þ b1x1 þ b2x2 þ b3x3 þ b11x21 þ b22x22 þ b33x23
þ b12x1x2 þ b13x1x3 þ b23x2x3Þ ð2Þ
In this study, the concentrations of independent variables were
adjusted as 0%, 4%, 8% (wt/wt) and also all formulations
contained 8% (wt/wt) buprenorphine as given in Table 1.
The effects of independent variables on dependent variables,
shown in three-dimensional plots, were obtained for responses
based on the effects of three variable factors at three levels.
Results and discussion
Skin permeation studies
Skin permeation across rat skin for 15 formulations, each con-
taining 8% (wt/wt) buprenorphine, was evaluated, and the re-
sults of permeation parameters were summarized and
presented in Table 2. The skin permeation ﬂux and the effects
of levulinic acid (LEV), lauryl alcohol (LA), and Tween 80 (T)
were determined by RSM to promote an empirical model. The
quadratic equations for skin permeation were developed, and
the ANOVA results for this model showed that the quadratic
equation was no lack of ﬁt, and the coefﬁcient of prediction
(R2) and adjusted (R2) were found to be 0.81 and 0.84, respec-Table 2 Skin permeation parameters.
Run (formulation number) Correlation coeﬃcient Sk
1 0.994 2.0
2 0.991 3.0
3 0.972 2.5
4 0.996 1.5
5 0.991 1.3
6 0.996 2.3
7 0.988 2.6
8 0.996 1.4
9 0.990 0.8
10 0.995 1.4
11 0.995 1.8
12 0.991 1.2
13 0.995 1.6
14 0.984 1.6
15 0.969 2.8
No enhancer 0.971 0.5
a n.d = this value cannot be determined.tively. This meant that the model equation achieved from
RSM was suitable to depict the skin permeation ﬂux underin permeation ﬂux (lg/cm2 h) SD Lag time (h)
26 0.5 0.81 ± 0.003
87 1.01 n.d a
44 1.001 4.27 ± 0.006
94 0.23 0.98 ± 0.007
41 0.02 2.57 ± 0.006
44 0.8 0.76 ± 0.001
69 0.8 n.d
45 0.12 1.36 ± 0.005
43 0.01 2.88 ± 0.001
73 0.1 1.38 ± 0.001
51 0.7 1.92 ± 0.006
82 0.3 1.26 ± 0.006
72 0.2 1.42 ± 0.004
81 0.86 3.36 ± 0.009
65 1.53 n.d
72 0.6 4.31 ± 0.003
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model adopted for skin permeation ﬂux was as follows:
Skin permeation flux ¼ 1:66þ 0:44ðLAÞ þ 0:2ðTÞ
þ 0:53ðLEVÞ þ 0:39ðLAÞ2
To investigate the effects of LEV, LA and T on skin perme-
ation of buprenorphine the response surface graphs were plot-
ted and presented in Fig. 1. The Table 2 is given to conﬁrm the
claim made by Fig. 1. The plots in Fig. 1 show that the skin
permeation ﬂux is enhanced with increase in LEV, LA, and
T percentages in each mixture. The simultaneous addition of
LEV, LA, and adhesive (run 3) has had an additional effect,
and hence, the skin permeation ﬂux is increased. As it is listed
in Table 2 and the coefﬁcient of LEV(0.53) in equation of skin
permeation ﬂux, among all enhancers, the addition of LEV to
the formulation (run 4) has resulted in higher skin permeation
ﬂux compared to formulations 9 (with lauryl alcohol only) and
10 (with Tween 80 only).
The effect of LA in enhancement of skin permeation ﬂux
could be due to the chemical structure of LA, because this fatty
alcohol might disrupt the intercellular lipid bi-layers and in-
crease the diffusion of the drug into the skin. Besides, LA
might ﬂuidize the lipids in stratum corneum (SC) and so in-
crease the partitioning of the drug into skin [21,22]. Therefore,
with increases in diffusion coefﬁcient and partitioning of drug,
the skin permeation ﬂux might be enhanced.Fig. 2 SEM micrographs of (A) sample 3
Fig. 3 Tack valueTween 80 as a non-ionic surfactant might enhance the skin
permeation ﬂux by two possible mechanisms. First, the surfac-
tants increase the ﬂuidity and solubility of lipid components of
SC followed by their permeation into the intercellular of the
SC. Then, the surfactants could come into interaction and bind
with keratin ﬁbrils and possibly disrupt the corneocyte. The
chemical structure of Tween 80 may help the skin permeation
of buprenorphine by lipophilic and hydrophilic mechanisms
and therefore enhancing the partition process between the lipo-
philic content and hydrophilic protein [16,23,24]. As it is illus-
trated in Table 2, among some types of additives used in this
study, the formulation containing LEV shows the highest skin
permeation ﬂux so it may have acted as a chemical skin pene-
tration enhancer. The enhancement of skin permeation ﬂux by
LEV may be associated with disrupting the intercellular lipid
domains [25], while Holas et al. [26] have reported the impor-
tant role of hydrogen bonding taking place between the perme-
ation enhancers and the drug. As our objective was to decrease
the interaction between the drug and the adhesive, therefore
the permeation of the drug through the skin was enhanced
by LEV which might have increased skin permeation ﬂux.
The results given in Table 2 demonstrate that the simultaneous
addition of LEV and LA into the mixture has boosted skin
permeation ﬂux compared to the mixture into which LEV
and other enhancers have been added. This is clearly evident
in SEM images, where the micrographs reveal higher solubility
of buprenorphine in the patch matrix (Fig. 2) of LEV-LA (run(B) sample 4 at 10,000· magniﬁcation.
for all samples.
Table 3 Glass transition temperature of samples.
Run (formulation number) Tg (C)
4 37
9 47.3
10 55.7
No enhancer 50.7
160 S.M. Taghizadeh et al.3) and LEV samples. These images contain white spots which
reveal the drug phase. The micrographs indicate that solubility
of drug in formulation 3 (run 3) is higher than formulation 4
(run 4). The reason for this behavior can be explained by
simultaneous addition of LEV and LA into the mixture and
its effect on skin permeation ﬂux.
Studies on adhesive properties (tack value and peel strength)
For prediction of tack value, a modiﬁed quadratic model was
used. The quadratic equations for tack have been developed
as:
Tack ¼ 4:65 0:23ðLAÞ þ 0:19ðTÞ þ 0:39ðLEVÞ  0:51ðLAÞ2
 0:71ðLAÞðTÞ  0:63ðLEVÞðTÞ
ANOVA table illustrates that the quadratic model has no
lack of ﬁt, and adjusted R2 and prediction R2 are close to each
other, and some factors such as LEV, LA \ T and T \ LEV are
signiﬁcant parameters, implies that P-value is less than 0.05.
These results are observed, and the selected model seems ade-
quate to show the actual relationship between the responses
and signiﬁcant variables.Fig. 4 Response surface for tack value versus (A) for T and LEV
at LA = 4% and (B) for LA and T at LEV = 4%.Tack is the property of adhesives that allows the immediate
formation of a bond with another surface under light contact
pressure. Tack is a complex response of adhesive surface and
bulk properties, so viscoelastic properties and glass transition
temperature of adhesive play important role in degree of tack
value [27]. It is worth mentioning that another sample (with no
enhancer) was prepared, besides other samples mentioned in
Table 1, with the following speciﬁcation:
LEV = 0%, LA= 0% and T = 0% (wt/wt) and desig-
nated as ‘‘no enhancer.’’
The reason for preparation of such sample was to estimate
the effect of additives on adhesion properties. As shown in
Fig. 3, by addition of each CPE to the mixture, the tack values
were found to be higher than a sample having ‘‘no enhancer,’’
and this aspect is included in tack value equation. It is evident
that in Fig. 4, all skin permeation enhancers show increased
tack value by up to 12% incorporated CPE adhesive.Fig. 5 Response surface for peel strength versus (A) for T and
LEV at LA = 4% and (B) for LA and LEV at T = 4%.
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tures in presence of each skin penetration enhancer. As it is
evident in samples containing LEV and LA of 4% (w/w) have
higher Tg and Tween 80 (in 4% w/w) has lower Tg. As it is
illustrated in Fig. 3, the tack values of all samples are higher
than the sample with ‘‘no enhancer’’ and so CPE has acted
as tackiﬁer, though according to Table 3, Tween 80 has acted
as a plasticizer, and LEV and LA have acted as tackiﬁers as
well. The effect of plasticizer has been reported to lower the
Tg and the modulus of the compound and thus increasing
the ﬂuidity of the adhesive and wetting of the adherent [28].
Therefore, the plasticizer has increased the tack value and
has provided viscous ﬂow of the adhesive for bonding with a
low deformation rate. On the other hand, LEV and LA which
have increased the Tg of the mixture might have also enhanced
the tack value due to increased G00 at higher frequency [27,29].
The equation below describes the modeling of peel strength
by using a quadratic model:
Peel strength ¼ 2:55þ 0:015ðLAÞ  5:69ðTÞ þ 0:3ðLEVÞ
 0:82ðLAÞ2 þ 4:85ðTÞ2 þ 0:22ðLEVÞ2
 0:42ðLAÞðTÞ þ 0:4ðLAÞðLEVÞ
 1:43ðTÞðLEVÞ
There has been no lack of ﬁt for this model. This model has
signiﬁcant terms such as T, LA2, T2, and T \ LEV. Therefore,
P-value is below 0.05 for these terms. Also, the adjusted R2
and prediction R2 were 0.98 and 0.94, respectively. Thus, this
model has best prediction for response. It is shown in Fig. 5
that the incorporation of just LEV or LA into the mixture
the peel strength would be higher than neat mixture (sample
without enhancer) which may also be proved by peel strength
equation as well. In Table 4, the coefﬁcients in dependent vari-
ables equation with their P-values are presented. By addition
of LEV and LA together into the mixture, the synergistic effectTable 4 Coefﬁcients of dependent variables equation with
their P-values.
CPE Coeﬃcient of equation P-value
Skin permeation
LA +0.44 0.046
T +0.2 0.044
LEV +0.53 0.049
LA2 +0.39 0.047
Tack
LA 0.23 0.051
T +0.19 0.053
LEV +0.39 0.049
LA2 0.51 0.051
(LA)(T) 0.71 0.046
(LEV)(T) 0.63 0.042
Peel strength
LA +0.015 0.052
T 5.69 0.039
LEV +0.3 0.051
LA2 0.82 0.041
T2 +4.85 0.036
LEV2 +0.22 0.052
(LA)(T) 0.42 0.051
(LA)(LEV) +0.4 0.053
(LEV)(T) 1.43 0.046on peel strength was observed. The reason for that was due to
increased Tg by addition of LEV and LA. Cantor et al. have
shown that there is a relationship between Tg and peel strength
of pressure sensitive adhesive [29]. In this respect, Kendall
et al. have reported that the peel adhesion increases with high-
er Tg [29] and Schrijvers et al. have stated that peel and tack
could be enhanced with increased Tg [29]. On the other hand,
Taghizadeh et al. have found that the peel strength is decreased
with lower Tg of the mixture [30]. Tween 80 reduces Tg of the
mixture by increasing the space between the entanglement and
free volume so it plays the role of a plasticizer. Therefore, the
results have shown that peel strength is decreased by addition
of Tween 80 into the mixture. It should be noted that the
above effects are found to be valid up to 12% CPEs incorpo-
rated into the adhesive and after that the peel strength is
dropped because of the relative reduction in adhesive content.
Conclusions
The effects of different types of chemical penetration enhanc-
ers on skin permeation ﬂux, tack value, and peel strength of
buprenorphine transdermal patches were investigated. It was
found that skin penetration ﬂux of buprenorphine and adhe-
sion properties of the patches were controlled by each perme-
ation enhancer concentration. LEV, LA, and Tween 80 could
enhance permeation ﬂux of buprenorphine through the skin.
Also, both LEV and LA together have had synergistic effect
on skin permeation ﬂux. According to adhesion properties, it
was observed that by addition of LEV, LA, and Tween 80 into
the matrix, the tack value was increased due to the two former
roles as tackiﬁers and Tween 80 acting as a plasticizer. On the
other hand by incorporation LEV and LA into the system, the
peel strength was increased and by addition of Tween 80 the
peel strength was reduced. All these effects were realized at
maximum 12% (wt/wt) chemical penetration enhancers incor-
porated into the system, which beyond that concentration the
adhesion properties (tack and peel) were reduced.
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